The upcoming report from Eli Lilly (LLY) is expected to reveal quarterly earnings of $5.15 per share, indicating an increase of 106.8% compared to the year-ago period. Analysts forecast revenues ...
14d
Zacks.com on MSNCompared to Estimates, Lilly (LLY) Q4 Earnings: A Look at Key MetricsThe headline numbers for Lilly (LLY) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street ...
17d
Zacks.com on MSNCurious about Lilly (LLY) Q4 Performance? Explore Wall Street Estimates for Key MetricsEvaluate the expected performance of Lilly (LLY) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics ...
17d
Zacks.com on MSNEli Lilly Stock Before Q4 Earnings: To Buy or Not to Buy?Eli Lilly and Company LLY will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $13.72 billion and ...
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
The recent surge has been due to the tremendous growth Lilly has achieved due to its highly popular GLP-1 drugs, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results